Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Bevacizumab 56Cetuximab 52Fluorouracil 46Oxaliplatin 39Leucovorin 39pembrolizumab 34Specimen Handling 29Irinotecan 25Magnetic Resonance Spectroscopy 18Biopsy 18Nivolumab 17Capecitabine 14trifluridine tipiracil drug combination 13HMPL-013 13Folfox protocol 13Panitumumab 12Gemcitabine 12Cisplatin 12Carboplatin 11encorafenib 9balstilimab 9Standard of Care 9Pemetrexed 9IFL protocol 9Trifluridine 8Paclitaxel 8Early Intervention, Educational 8130-nm albumin-bound paclitaxel 8regorafenib 7fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Genetic Profile × 90 days × Clear all
NCT04905082 2026-03-24

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

City of Hope Medical Center

Phase NA Active not recruiting
465 enrolled 11 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡